TGF-β1-induced phospholamban expression alters esophageal smooth muscle cell contraction in patients with eosinophilic esophagitis

Journal of Allergy and Clinical Immunology

Volumn 134, Issue 5, 2014, Pages 1100-1107.e4

  Beppu, Lisa Y ^a,b   Anilkumar, Arjun A ^a,c   Newbury, Robert O ^a,b   Dohil, Ranjan ^a,b   Broide, David H ^a,c   Aceves, Seema S ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

eosinophils; esophagus; phospholamban; Remodeling; smooth muscle; TGF

Indexed keywords

PHOSPHOLAMBAN; REGULATOR PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; CALCIUM BINDING PROTEIN; MUSCLE PROTEIN; TGFB1 PROTEIN, HUMAN;

ARTICLE; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; EOSINOPHIL; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS BIOPSY; ESOPHAGUS MUSCLE; FIBROBLAST; FLUORESCENCE ACTIVATED CELL SORTING; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO STUDY; MUSCLE FIBER CONTRACTION; MYOFIBROBLAST; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RUMINANT STOMACH; SARCOPLASMIC RETICULUM; SMOOTH MUSCLE FIBER; ADULT; BIOSYNTHESIS; CELL CULTURE; ESOPHAGUS; FEMALE; GENE EXPRESSION REGULATION; MALE; METABOLISM; MUSCLE CONTRACTION; PATHOLOGY; PATHOPHYSIOLOGY; PHOSPHORYLATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; CALCIUM-BINDING PROTEINS; CELLS, CULTURED; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MUSCLE CONTRACTION; MUSCLE PROTEINS; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84914170420     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2014.04.004     Document Type: Article

References (47)

1. C.A. Liacouras, G.T. Furuta, I. Hirano, D. Atkins, S.E. Attwood, and P.A. Bonis Eosinophilic esophagitis: updated consensus recommendations for children and adults J Allergy Clin Immunol 128 2011 3 20
2. S.S. Aceves, R.O. Newbury, R. Dohil, J.F. Bastian, and D.H. Broide Esophageal remodeling in pediatric eosinophilic esophagitis J Allergy Clin Immunol 119 2007 206 212
3. M.A. Kwiatek, I. Hirano, P.J. Kahrilas, J. Rothe, D. Luger, and J.E. Pandolfino Mechanical properties of the esophagus in eosinophilic esophagitis Gastroenterology 140 2011 82 90
4. F. Nicodeme, I. Hirano, J. Chen, K. Robinson, Z. Lin, and Y. Xiao Esophageal distensibility as a measure of disease severity in patients with eosinophilic esophagitis Clin Gastroenterol Hepatol 11 2013 1101 1107
5. A. Straumann The natural history and complications of eosinophilic esophagitis Gastrointest Endosc Clin N Am 18 2008 99 118
6. A.J. Lucendo Motor disturbances participate in the pathogenesis of eosinophilic oesophagitis, beyond the fibrous remodelling of the oesophagus Aliment Pharmacol Ther 24 2006 1264 1267
7. A.J. Lucendo, A. Arias, L.C. De Rezende, J.L. Yague-Compadre, T. Mota-Huertas, and S. Gonzalez-Castillo Subepithelial collagen deposition, profibrogenic cytokine gene expression, and changes after prolonged fluticasone propionate treatment in adult eosinophilic esophagitis: a prospective study J Allergy Clin Immunol 128 2011 1037 1046
8. A.M. Schoepfer, E. Safroneeva, C. Bussmann, T. Kuchen, S. Portmann, and H.U. Simon Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation, in a time-dependent manner Gastroenterology 145 2013 1230 1236
9. E.S. Dellon, H.P. Kim, S.L. Sperry, D.A. Rybnicek, J.T. Woosley, and N.J. Shaheen A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease Gastrointest Endosc 79 2014 577 585.e4
10. S.S. Aceves, D. Chen, R.O. Newbury, R. Dohil, J.F. Bastian, and D.H. Broide Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction J Allergy Clin Immunol 126 2010 1198 1204
11. R. Niranjan, P. Mavi, M. Rayapudi, S. Dynda, and A. Mishra Pathogenic role of mast cells in experimental eosinophilic esophagitis Am J Physiol Gastrointest Liver Physiol 304 2013 G1087 G1094
12. M. Chehade, H.A. Sampson, R.A. Morotti, and M.S. Magid Esophageal subepithelial fibrosis in children with eosinophilic esophagitis J Pediatr Gastroenterol Nutr 45 2007 319 328
13. S. Roman, I. Hirano, M.A. Kwiatek, N. Gonsalves, J. Chen, and P.J. Kahrilas Manometric features of eosinophilic esophagitis in esophageal pressure topography Neurogastroenterol Motil 23 2011 208 214
14. A.J. Read, and J.E. Pandolfino Biomechanics of esophageal function in eosinophilic esophagitis J Neurogastroenterol Motil 18 2012 357 364
15. H. Korsapati, A. Babaei, V. Bhargava, R. Dohil, A. Quin, and R.K. Mittal Dysfunction of the longitudinal muscles of the oesophagus in eosinophilic oesophagitis Gut 58 2009 1056 1062
16. R.T. Landres, G.G. Kuster, and W.B. Strum Eosinophilic esophagitis in a patient with vigorous achalasia Gastroenterology 74 1978 1298 1301
17. R.J. Noel, P.E. Putnam, and M.E. Rothenberg Eosinophilic esophagitis N Engl J Med 351 2004 940 941
18. S. Nurko, R. Rosen, and G.T. Furuta Esophageal dysmotility in children with eosinophilic esophagitis: a study using prolonged esophageal manometry Am J Gastroenterol 104 2009 3050 3057
19. F.J. Moawad, C.L. Maydonovitch, G.R. Veerappan, J.T. Bassett, J.M. Lake, and R.K. Wong Esophageal motor disorders in adults with eosinophilic esophagitis Dig Dis Sci 56 2011 1427 1431
20. E. Savarino, L. Gemignani, P. Zentilin, N. De Bortoli, A. Malesci, and L. Mastracci Achalasia with dense eosinophilic infiltrate responds to steroid therapy Clin Gastroenterol Hepatol 9 2011 1104 1106
21. J. Bassett, C. Maydonovitch, J. Perry, L. Sobin, E. Osgard, and R. Wong Prevalence of esophageal dysmotility in a cohort of patients with esophageal biopsies consistent with eosinophilic esophagitis Dis Esophagus 22 2009 543 548
22. R.A. Hejazi, S.C. Reddymasu, S. Sostarich, and R.W. McCallum Disturbances of esophageal motility in eosinophilic esophagitis: a case series Dysphagia 25 2010 231 237
23. A. Mishra, M. Wang, V.R. Pemmaraju, M.H. Collins, P.C. Fulkerson, and J.P. Abonia Esophageal remodeling develops as a consequence of tissue specific IL-5-induced eosinophilia Gastroenterology 134 2008 204 214
24. P. Mavi, P. Rajavelu, M. Rayapudi, R.J. Paul, and A. Mishra Esophageal functional impairments in experimental eosinophilic esophagitis Am J Physiol Gastrointest Liver Physiol 302 2012 G1347 G1355
25. J.P. Abonia, J.P. Franciosi, and M.E. Rothenberg TGF-beta1: Mediator of a feedback loop in eosinophilic esophagitis - or should we really say mastocytic esophagitis? J Allergy Clin Immunol 126 2010 1205 1207
26. A. Straumann, H.P. Spichtin, L. Grize, K.A. Bucher, C. Beglinger, and H.U. Simon Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5 years Gastroenterology 125 2003 1660 1669
27. A. Straumann, S. Conus, L. Degen, S. Felder, M. Kummer, and H. Engel Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis Gastroenterology 139 2010 1526 1537
28. J.P. Schmitt, M. Kamisago, M. Asahi, G.H. Li, F. Ahmad, and U. Mende Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban Science 299 2003 1410 1413
29. K. Haghighi, F. Kolokathis, A.O. Gramolini, J.R. Waggoner, L. Pater, and R.A. Lynch A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy Proc Natl Acad Sci U S A 103 2006 1388 1393
30. P. Baum, K. Fundel-Clemens, S. Kreuz, R.E. Kontermann, A. Weith, and D. Mennerich Off-target analysis of control siRNA molecules reveals important differences in the cytokine profile and inflammation response of human fibroblasts Oligonucleotides 20 2010 17 26
31. E.G. Kranias, and R.J. Hajjar Modulation of cardiac contractility by the phospholamban/SERCA2a regulatome Circ Res 110 2012 1646 1660
32. A. Ramachandran, S.S. Gangopadhyay, R. Krishnan, S.A. Ranpura, K. Rajendran, and S. Ram-Mohan JunB mediates basal- and TGFbeta1-induced smooth muscle cell contractility PLoS One 8 2013 e53430
33. V.L. Fox, S. Nurko, J.E. Teitelbaum, K. Badizadegan, and G.T. Furuta High-resolution EUS in children with eosinophilic "allergic" esophagitis Gastrointest Endosc 57 2003 30 36
34. A. Straumann, S. Conus, L. Degen, C. Frei, C. Bussmann, and C. Beglinger Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis Clin Gastroenterol Hepatol 9 2011 400 409
35. M. Remedios, C. Campbell, D.M. Jones, and P. Kerlin Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate Gastrointest Endosc 63 2006 3 12
36. H. Saffari, K.A. Peterson, J.C. Fang, C. Teman, G.J. Gleich, and L.F. Pease 3rd Patchy eosinophil distributions in an esophagectomy specimen from a patient with eosinophilic esophagitis: implications for endoscopic biopsy J Allergy Clin Immunol 130 2012 798 800
37. A.G. Nicholson, D. Li, U. Pastorino, P. Goldstraw, and P.K. Jeffery Full thickness eosinophilia in oesophageal leiomyomatosis and idiopathic eosinophilic oesophagitis. A common allergic inflammatory profile? J Pathol 183 1997 233 236
38. F. Rieder, I. Nonevski, J. Ma, Z. Ouyang, G. West, and C. Protheroe T-helper 2 cytokines, transforming growth factor β1, and eosinophil products induce fibrogenesis and alter muscle motility in patients with eosinophilic esophagitis Gastroenterology 2014 [Epub ahead of print]
39. H.S. Wang, D.A. Arvanitis, M. Dong, P.J. Niklewski, W. Zhao, and C.K. Lam SERCA2a superinhibition by human phospholamban triggers electrical and structural remodeling in mouse hearts Physiol Genom 43 2011 357 364
40. K. Haghighi, F. Kolokathis, L. Pater, R.A. Lynch, M. Asahi, and A.O. Gramolini Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human J Clin Invest 111 2003 869 876
41. V. Sathish, M.A. Thompson, J.P. Bailey, C.M. Pabelick, Y.S. Prakash, and G.C. Sieck Effect of proinflammatory cytokines on regulation of sarcoplasmic reticulum Ca2+ reuptake in human airway smooth muscle Am J Physiol Lung Cell Mol Physiol 297 2009 L26 L34
42. D.W. McGraw, K.M. Fogel, S. Kong, A.A. Litonjua, E.G. Kranias, and B.J. Aronow Transcriptional response to persistent beta2-adrenergic receptor signaling reveals regulation of phospholamban, which alters airway contractility Physiol Genom 27 2006 171 177
43. M. Kim, G.W. Hennig, K. Park, I.S. Han, T.K. Smith, and S.D. Koh Modulation of murine gastric antrum smooth muscle STOC activity and excitability by phospholamban J Physiol 586 2008 4977 4991
44. M. Kim, G.W. Hennig, T.K. Smith, and B.A. Perrino Phospholamban knockout increases CaM kinase II activity and intracellular Ca2+ wave activity and alters contractile responses of murine gastric antrum Am J Physiol Cell Physiol 294 2008 C432 C441
45. C. Camello-Almaraz, B. Macias, P.J. Gomez-Pinilla, S. Alcon, F.E. Martin-Cano, and A. Baba Developmental changes in Ca2+ homeostasis and contractility in gallbladder smooth muscle Am J Physiol Cell Physiol 296 2009 C783 C791
46. S. Qureshi, J. Song, H.T. Lee, S.D. Koh, G.W. Hennig, and B.A. Perrino CaM kinase II in colonic smooth muscle contributes to dysmotility in murine DSS-colitis Neurogastroenterol Motil 22 2010 186 195
47. H. Fischer, J. Fischer, P. Boknik, U. Gergs, W. Schmitz, and W. Domschke Reduced expression of Ca2+-regulating proteins in the upper gastrointestinal tract of patients with achalasia World J Gastroenterol 12 2006 6002 6007